3 days popular7 days popular1 month popular3 months popular

Patients With HIV May Benefit From Quadruple The Standard Dose Of Seasonal Flu Vaccine

Administering a quadruple dose of may help better protect -infected patients from serious illness or death from . In a randomized, double-blind, controlled trial, 190 HIV-positive adults were randomly assigned to receive either a standard dose (15 mcg of antigen per strain) or a high dose (60 mcg/strain) of the trivalent vaccine. Participants were included if they were indicated for a flu vaccine and were receiving stable antiretroviral therapy as recommended by current guidelines.

The researchers found that the high dose patients achieved greater immune response as measured by their levels of seroprotective antibodies at 21 to 28 days after vaccination. Adverse event rates were similar in the two intervention groups.

According to the researchers, these findings could have implications for future vaccination efforts in the HIV-positive population.


Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons: A Single-Center, Parallel, Randomized Trial, Noah McKittrick, MD; Ian Frank, MD; , MD; C. Jo White, MD; , RPh; , RN, MPH; Carol DiGiorgio, RN; Thomas Kenney, BS; Jean Boyer, PhD; Pablo Tebas, MD, Ann Intern Med. 1 January 2013;158(1):19-26

American College of Physicians